Project Number 2U19AG010483-22 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for EXERCISE TRIAL Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 9. Non-Pharmacological Interventions a. Exercise Category G. Consortia and Public Private Partnerships 1. Consortia Researcher and Organization Principal Investigator BAKER, LAURA D. Principal Investigator First Name LAURA D. Principal Investigator Last Name BAKER Awardee Organization UNIVERSITY OF CALIFORNIA SAN DIEGO Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-001: Limited Competition: Alzheimer's Disease Cooperative Study (U19) FY Overall Cost $1,644,735 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Special Initiative Alzheimer's Disease Cooperative Study (ADCS) Related Resources Repository [AlzPED] CRF receptor-1 antagonism mitigates Aβ pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease [AlzPED] Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. [AMP-AD Knowledge Portal] Alzheimer’s Disease Cooperative Study (ADCS) Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial (A4 Trial) Clinical Trial Prazosin for Agitation in Alzheimer's Disease Exercise in Adults With Mild Memory Problems Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
